| (Values in U.S. Thousands) | Dec, 2020 | Dec, 2019 | Dec, 2018 | Dec, 2017 | Dec, 2016 |
| Sales | 2,070 | 350 | 0 | 0 | 0 |
| Sales Growth | +491.43% | unch | unch | unch | unch |
| Net Income | -9,460 | -9,690 | -4,340 | -3,860 | -1,600 |
| Net Income Growth | +2.37% | -123.27% | -12.44% | -141.25% | -357.14% |
Exactus Inc (EXDI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Exactus, Inc. is a life science company. It engaged in developing and commercializing point-of-care diagnostics for measuring proteolytic enzymes in the blood. The company's lead product consists of FibriLyzer(TM) and MatriLyzer (TM). Exactus, Inc. is based in Richmond, Virginia.